AOD-9604 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Pairs with CJC-1295/Ipamorelin for enhanced body composition (AOD handles fat loss while GH peptides handle lean mass). Also complements fasting and HIIT training protocols. Proper stacking requires understanding each compound's mechanism and timing.
What Is AOD-9604 Stacking?
Stacking means combining AOD-9604 with one or more complementary peptides to potentially achieve synergistic effects. Because different peptides work through different mechanisms, strategic combinations can target multiple pathways simultaneously.
AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog researched for fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
What Is the Best AOD-9604 Stack?
Pairs with CJC-1295/Ipamorelin for enhanced body composition (AOD handles fat loss while GH peptides handle lean mass). Also complements fasting and HIIT training protocols.
This combination is popular because it targets multiple mechanisms without significant overlap in side-effect profiles.
How Does AOD-9604 Stack With CJC-1295?
CJC-1295 (CJC-1295 (Modified GRF 1-29)) is a Growth Hormone Releasing Hormone (GHRH) analog that works through CJC-1295 binds to GHRH receptors on anterior pituitary somatotrophs, stimulating growth hormone synthesis and pulsatile secretion through the cAMP-PKA.
Combined with AOD-9604's effects on fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation, this stack covers increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects as well.
Typical stacking protocol: AOD-9604 at 250-1000 mcg daily once daily, ideally morning fasted alongside CJC-1295 at 100-300 mcg 1-3 times daily, typically before bed. See our CJC-1295 guide for details.
How Does AOD-9604 Stack With Ipamorelin?
Ipamorelin (Ipamorelin) is a Growth Hormone Secretagogue (GHS) / Ghrelin mimetic that works through Ipamorelin selectively stimulates GH release by mimicking ghrelin at the GHS-R receptor on pituitary somatotrophs. Unlike other GHRPs (GHRP-2, GHRP-6,.
Combined with AOD-9604's effects on fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation, this stack covers growth hormone release, improved sleep, fat loss, muscle recovery, bone density support as well.
Typical stacking protocol: AOD-9604 at 250-1000 mcg daily once daily, ideally morning fasted alongside Ipamorelin at 200-300 mcg 2-3 times daily. See our Ipamorelin guide for details.
How Does AOD-9604 Stack With Dihexa?
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a Synaptogenic neuropeptide, HGF/c-Met pathway agonist that works through Potentiates hepatocyte growth factor (HGF) and its receptor c-Met, driving synaptogenesis (new synapse formation). Preclinical data shows it is millio.
Combined with AOD-9604's effects on fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation, this stack covers enhanced synaptogenesis, improved cognitive function, memory enhancement, neuroprotection, increased dendritic spine density as well.
Typical stacking protocol: AOD-9604 at 250-1000 mcg daily once daily, ideally morning fasted alongside Dihexa at 10-40 mg daily once daily. See our Dihexa guide for details.
How Do You Time a AOD-9604 Stack?
When stacking, timing each injection based on half-life is important. AOD-9604 has a half-life of not established, which influences when to administer relative to other compounds.
Some researchers inject all peptides at the same time; others stagger by 15-30 minutes. There's limited data on whether timing within the same session matters significantly.
What Should You NOT Stack With AOD-9604?
Avoid stacking peptides with similar mechanisms of action at full doses — this can lead to receptor desensitization without proportional benefit. Also avoid combining compounds where side-effect profiles overlap significantly.
When in doubt, introduce one new compound at a time to isolate its effects before building a full stack.
Calculate Your AOD-9604 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for AOD-9604.
Open Calculator →Bottom Line on AOD-9604 Stacking
Pairs with CJC-1295/Ipamorelin for enhanced body composition (AOD handles fat loss while GH peptides handle lean mass). Also complements fasting and HIIT training protocols. Start with a single compound, assess response, then add complements.
See our stacking and cycling guide for general principles.
Complete Guide
AOD-9604: The Fat Loss Peptide Fragment
Related Reading
- AOD-9604 Dosage Guide
- AOD-9604 Benefits
- AOD-9604 Side Effects
- AOD-9604 Cycle Guide
- AOD-9604 Research
- CJC-1295 Complete Guide
Research-Grade Sourcing
If you're going to research AOD-9604, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is AOD-9604?
AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog. Synthetic analog of human GH fragment 177-191, engineered to selectively activate lipolysis without systemic GH effects. It is researched for fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
What is the recommended AOD-9604 dosage?
Common dosages: 250-1000 mcg daily administered once daily, ideally morning fasted via subcutaneous injection. Cycle length: 12-24 weeks. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of AOD-9604?
Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability.
Is AOD-9604 safe?
AOD-9604 has shown a favorable safety profile in research. Not FDA-approved. Development discontinued 2007. Available as research chemical. All research should follow appropriate safety protocols.